TRSBF Financial Statements & Analysis
Complete financial statements for TRSBF including income statement, balance sheet, and cash flow statement. Analyze TRSBF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
89.3% ↑
Net Income
295.3% ↑
Gross Margin
7.5% ↑
Operating Margin
98.9% ↑
Balance Sheet
Current Ratio
200.1% ↑
Debt to Equity
-58.2% ↑
Asset Turnover
26.4% ↑
Cash Flow
Operating Cash Flow
202.0% ↑
Net Cash Flow
2241.8% ↑
Free Cash Flow
307.8% ↑
Cash Flow to Debt
309.9% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 9.11B | 17.24B | 89.3% | |
| Gross Profit | 7.83B | 15.93B | 103.4% | |
| Operating Income | 2.73B | 10.29B | 276.5% | |
| Net Income | 2.09B | 8.26B | 295.3% | |
| EPS | 0.86 | 3.43 | 298.8% | |
| EBITDA | 3.30B | 10.81B | 227.3% | |
| Gross Margin | 85.95% | 92.38% | 7.5% | |
| Operating Margin | 29.99% | 59.66% | 98.9% | |
| Net Income Margin | 22.95% | 47.93% | 108.9% | |
| R&D Expenses | 1.33B | 1.48B | 11.7% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 17.24B | 9.11B | 7.82B | — | — |
| Gross Profit | 15.93B | 7.83B | 6.64B | — | — |
| Operating Income | 10.29B | 2.73B | 2.46B | — | — |
| Net Income | 8.26B | 2.09B | 1.55B | — | — |
| EPS | 3.43 | 0.86 | 0.63 | — | — |
| EBITDA | 10.81B | 3.30B | 2.53B | — | — |
| Gross Margin | 92.38% | 85.95% | 84.98% | — | — |
| Operating Margin | 59.66% | 29.99% | 31.45% | — | — |
| Net Income Margin | 47.93% | 22.95% | 19.82% | — | — |
| R&D Expenses | 1.48B | 1.33B | 794.79M | — | — |
Financial Metrics
Want to dive deeper into TRSBF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics